MDT

88.02

+0.36%↑

120.93

+3.42%↑

VEEV

157.02

-0.17%↓

HQY

80.21

+0.54%↑

TLRY

6.89

+2.53%↑

MDT

88.02

+0.36%↑

120.93

+3.42%↑

VEEV

157.02

-0.17%↓

HQY

80.21

+0.54%↑

TLRY

6.89

+2.53%↑

MDT

88.02

+0.36%↑

120.93

+3.42%↑

VEEV

157.02

-0.17%↓

HQY

80.21

+0.54%↑

TLRY

6.89

+2.53%↑

MDT

88.02

+0.36%↑

120.93

+3.42%↑

VEEV

157.02

-0.17%↓

HQY

80.21

+0.54%↑

TLRY

6.89

+2.53%↑

MDT

88.02

+0.36%↑

120.93

+3.42%↑

VEEV

157.02

-0.17%↓

HQY

80.21

+0.54%↑

TLRY

6.89

+2.53%↑

Home・Aktien・Lisata Therapeutics

L
Lisata Therapeutics

Open

4.78 -4.21

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

4.71

Max

Schlüsselkennzahlen
By Trading Economics
Einkommen	1.3M -3M
Verkäufe	100K 100K
Gewinnspanne	-2,954
Angestellte	21

Dividenden
By Dow Jones
Nächstes Ergebnis	7. Mai 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-208K 39M
Vorheriger Eröffnungskurs	8.99
Vorheriger Schlusskurs	4.78

Lisata Therapeutics Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

13. Apr. 2026, 23:25 UTC

Wichtige Nachrichtenereignisse

Westpac Expects Higher Loan Losses as Iran Conflict Slows Australian Economy -- Update

13. Apr. 2026, 22:45 UTC

Wichtige Nachrichtenereignisse

Westpac Expects Higher Loan Losses as Iran Conflict Slows Australian Economy

13. Apr. 2026, 18:03 UTC

Ergebnisse

Louis Vuitton Owner Logs Weak Sales as Middle East War Takes Toll -- 2nd Update

13. Apr. 2026, 23:58 UTC

Ergebnisse

Review & Preview: Earnings Time -- Barrons.com

13. Apr. 2026, 23:49 UTC

Market Talk

Nikkei May Rise After Overnight Gains on Wall Street -- Market Talk

13. Apr. 2026, 23:33 UTC

Market Talk

Wichtige Nachrichtenereignisse

Gold Edges Higher Amid Dollar Weakness -- Market Talk

13. Apr. 2026, 23:20 UTC

Market Talk

Uranium Stocks Seen Benefiting From Energy Security Concerns -- Market Talk

13. Apr. 2026, 23:01 UTC

Ergebnisse

Aura: Capex Guidance Revised From $111M and $130M to New Range of $262M and $314M >AURA33.SA.BR

13. Apr. 2026, 23:01 UTC

Ergebnisse

Aura Minerals: Announces Update to Capex Guidance Including Construction of the Era Dorada Project

13. Apr. 2026, 23:01 UTC

Ergebnisse

Aura: Will Update Cap Expenditure Guidance to Include the Project's Construction Phase >AURA33.SA.BR

13. Apr. 2026, 22:21 UTC

Akquisitionen, Fusionen, Übernahmen

Chevron Swaps Offshore Gas Stakes to Boost Venezuelan Heavy-Oil Footprint -- Update

13. Apr. 2026, 21:53 UTC

Ergebnisse

MarketWise, Inc.: Affirms FY 2026 Guidance, Including Div Target to Class A Hldrs of $1.80 per Shr

13. Apr. 2026, 21:53 UTC

Ergebnisse

MarketWise, Inc.: Paid Subscribers Were 381,000 at March 31 Compared to 374,000 at Dec 31, 2025, Active Free Subscribers Were 2.0M at March 31 >MKTW

13. Apr. 2026, 21:53 UTC

Ergebnisse

MarketWise, Inc.: 1Q Billings Increased Approximately 15% Yr-over-Yr to Approximately $81M

13. Apr. 2026, 21:53 UTC

Ergebnisse

MarketWise, Inc.: Preliminary Selected Unaudited 1Q Paid Subscribers Returning to Growth

13. Apr. 2026, 21:26 UTC

Wichtige Nachrichtenereignisse

U.S. Oil Blockade Is Set to Boost American Exports -- and Prices at the Pump -- WSJ

13. Apr. 2026, 21:23 UTC

Ergebnisse

Johnson & Johnson Earnings: Oncology Powers Growth, but Talc Lawsuits Persist -- Barrons.com

13. Apr. 2026, 21:16 UTC

Ergebnisse

Goldman Sachs Reports Record Quarter in Banking and Trading -- 4th Update

13. Apr. 2026, 20:50 UTC

Market Talk

Wichtige Nachrichtenereignisse

Basic Materials Roundup: Market Talk

13. Apr. 2026, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

13. Apr. 2026, 20:34 UTC

Ergebnisse

Victory Capital: 1Q Long-Term AUM Net Flows of -$457M >VCTR

13. Apr. 2026, 20:34 UTC

Ergebnisse

Victory Capital: March Avg Total AUM Was $315.3B, Avg Other Assets $3.2B, Avg Total Client Assets $318.5B >VCTR

13. Apr. 2026, 20:34 UTC

Ergebnisse

Victory Capital Holdings, Inc.: Total Assets Under Management of $309.8B, Other Assets $3.3B, Total Client Assets of $313.1B as of March 31 >VCTR

13. Apr. 2026, 19:59 UTC

Market Talk

Canada Consumers Sour Prior to Big Energy-Price Jump -- Market Talk

13. Apr. 2026, 19:50 UTC

Market Talk

Wichtige Nachrichtenereignisse

Oil Futures Pull Back From Highs on Hopes for Talks -- Market Talk

13. Apr. 2026, 19:27 UTC

Market Talk

Wichtige Nachrichtenereignisse

Correction to Precious Metals Market Talk on April 9

13. Apr. 2026, 19:14 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower on Mild Weather -- Market Talk

13. Apr. 2026, 18:59 UTC

Market Talk

Wichtige Nachrichtenereignisse

Fed's Goolsbee: Don't Be Surprised If Consumer Confidence Sours -- Market Talk

13. Apr. 2026, 18:59 UTC

Market Talk

Wichtige Nachrichtenereignisse

Fed's Goolsbee: Oil Shows People Expect Short Term Conflict in Iran -- Market Talk

13. Apr. 2026, 18:43 UTC

Market Talk

Precious Metals Lose Ground as U.S. Blockade in Hormuz Gets Underway -- Market Talk

Peer-Vergleich

Kursveränderung

Lisata Therapeutics Prognose

Rating-Konsens

By TipRanks

Neutral

1 ratings

Buy

Halten

Sell

Basierend auf 1 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lisata Therapeutics – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Gewinn vor Steuern

Verkäufe

Betriebsergebnis

Über Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.